Roche Holding AG (XSWX:RO) 3-Year Revenue Growth Rate : 3.70% (As of Jun. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Roche Holding AG 3-Year Revenue Growth Rate?

Roche Holding AG's Revenue per Share for the six months ended in Jun. 2024 was CHF38.35.

During the past 12 months, Roche Holding AG's average Revenue per Share Growth Rate was -2.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Roche Holding AG was 15.50% per year. The lowest was -2.30% per year. And the median was 3.40% per year.

Competitive Comparison of Roche Holding AG's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, Roche Holding AG's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's 3-Year Revenue Growth Rate falls into.

Roche Holding AG 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Roche Holding AG (XSWX:RO) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Roche Holding AG 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (XSWX:RO) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBY:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0TDF:UK 0QQ6:UK 0QOK:UK RHO6:Germany ROG:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG Headlines

No Headlines